Drug reference

tebentafusp-tebn

Mosby’s 2024 Nursing Drug Reference

Source: Mosby’s 2024 Nursing Drug Reference
PDF pages: 1415

Review source pages for extracted sections and age labels.

Overview

Names and pronunciation

Kimmtrak

PDF page 1415

Functional class

Func. class.: Antineoplastic

PDF page 1415

Uses

USES: HLA-A*02:01-positive unresect- able/metastatic uveal melanoma

PDF page 1415

Dose and formulations

Dosage and routes

DOSAGE AND ROUTES Adults: IV 20 mcg day 1, 30 mcg day 8, 68 mcg day 15, then 68 mcg once weekly until disease progression.

PDF page 1415

Available forms

Available forms: Solution for injection 100 mcg/0.5 mL

PDF page 1415

Age labels are extracted for navigation. Check the complete source section and current local guidance before clinical use.

Drug reference

tebentafusp-tebn

Mosby’s 2024 Nursing Drug Reference

Source: Mosby’s 2024 Nursing Drug Reference
PDF pages: 1415

Review source pages for extracted sections and age labels.

Overview

Names and pronunciation

Kimmtrak

PDF page 1415

Functional class

Func. class.: Antineoplastic

PDF page 1415

Uses

USES: HLA-A*02:01-positive unresect- able/metastatic uveal melanoma

PDF page 1415

Dose and formulations

Dosage and routes

DOSAGE AND ROUTES Adults: IV 20 mcg day 1, 30 mcg day 8, 68 mcg day 15, then 68 mcg once weekly until disease progression.

PDF page 1415

Available forms

Available forms: Solution for injection 100 mcg/0.5 mL

PDF page 1415

Age labels are extracted for navigation. Check the complete source section and current local guidance before clinical use.

tebentafusp-­tebn

Overview

Names and pronunciation

Functional class

Uses

Dose and formulations

Dosage and routes

Available forms

tebentafusp-­tebn

Overview

Names and pronunciation

Functional class

Uses

Dose and formulations

Dosage and routes

Available forms

tebentafusp-tebn

tebentafusp-tebn